Skip to content

Single Use Bronchoscopes for Interventional Pulmonology

Implementation of Low-Cost Single-Use Flexible Bronchoscopes for Routine Interventional Pulmonary Procedures: A Feasibility Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06596655
Enrollment
20
Registered
2024-09-19
Start date
2025-05-23
Completion date
2027-10-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchoscopic Interventions

Brief summary

The goal of this pilot single-arm crossover trial is to investigate the feasibility and safety of using single-use flexible bronchoscopes (SUFB) for routine diagnostic and therapeutic interventional pulmonary procedures instead of reusable flexible bronchoscopes (RFB). The main questions it aims to answer are: Was a decision to crossover from SUFB to RFB (at the discretion of the clinical bronchoscopist) made ? Bronchoscopist's assessment of the SUFB for each procedure (using a Likert scale 0-10) including: 1. Overall assessment 2. Scope quality 3. Scope handling 4. Scope maneuverability 5. Tool compatibility 6. Suction 7. Lavage 8. Safety 9. Image quality Participants will undergo bronchoscopy with single use bronchoscopes.

Interventions

Use of single use bronchoscopes for interventional pulmonology procedures instead of reusable bronchoscopes.

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER
Olympus
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Able to provide informed consent.

Exclusion criteria

1. Emergent procedure 2. Pregnancy 3. Study subjects have any diseases or conditions that interferes with safe completion of the biopsy including: cardiopulmonary instability; sensitivity to drugs that could be administered during bronchoscopy; active anticoagulation or antiplatelet therapy (warfarin, direct Xa inhibitors, thrombin inhibitors, low molecular weight heparin, unfractioned heparin, clopidogrel) not held adequately prior to the procedure; uncontrolled blood dyscrasias; concurrent pneumothorax or bullae.

Design outcomes

Primary

MeasureTime frame
Incidence of crossover from SUFB to RFB (at the discretion of the clinical bronchoscopist)During the procedure

Countries

United States

Contacts

CONTACTChristine Conley
Cconley@bidmc.harvard.edu617-632-8386

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026